Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/21/2000US6040430 Nucleic acid encoding site specific recombinase and nuclear receptor fusion protein
03/21/2000US6040429 Congenital heart disease proteins and products related thereto
03/21/2000US6040428 Porcine E-selectin
03/21/2000US6040426 Human Th2 specific protein
03/21/2000US6040423 Solid phase synthesis using one-piece support to synthesize a plurality of different peptides by spotting n-protected amino acid solution in discrete zones, coupling c-terminal to support, then coupling additional amino acids
03/21/2000US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
03/21/2000US6040295 Prolong the bioavailability of a nucleic acid molecule by injecting a solutions comprising a nucleic acid molecule and an amphiphilic compound select from polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol or propylene glycol
03/21/2000US6040293 A microbial polypeptides with antimicrobial activity; fungicides, viricides, bactericides
03/21/2000US6040193 Combinatorial strategies for polymer synthesis
03/21/2000US6040185 A nucleic acid molecule genetically engineered conferring a stable phenotype with gene on transgenic plant
03/21/2000US6040184 Method for more efficient electroporation
03/21/2000US6040183 Helper virus-free AAV production
03/21/2000US6040181 Regulation of bcl-2 gene expression
03/21/2000US6040179 Antisense inhibition of G-alpha-i2 expression
03/21/2000US6040178 Compound 8 to 30 nucleobases in length targeted to coding region or 5' untranslated region of a nucleic acid encoding a human transcription factor regulated by, and mediator of, bone morphogenic proteins; for treatment of related diseases
03/21/2000US6040177 Adding large number of non-dividing peripheral blood mononuclear cells as feeder cells to t-cells in culture medium, activating t-cell receptor complex, adding vector and incubating producing antigen-specific and restricted cells
03/21/2000US6040176 Monoclonal antibody produced by the hybridoma cell line 81k2f (atcc hb 11692) which acts against human intercellular adhesion molecule-r; antiinflammatory/antitumor agents; antimetastasis agents; viricides
03/21/2000US6040175 AMPA-binding human GluR2 receptors
03/21/2000US6040174 Defective adenoviruses and corresponding complementation lines
03/21/2000US6040172 Defective DNA viral vector comprising a neural tissue-specific promoter for in vivo expression of a gene
03/21/2000US6040170 Human cytomegalovirus DNA sequences
03/21/2000US6040168 Dna and amino acid sequence of protein involved in neurotransmission and neurodevelopment; for diagnosis and treatment of schizophrenia and other nervous system disorders; screening drugs
03/21/2000US6040166 Kits for amplifying and detecting nucleic acid sequences, including a probe
03/21/2000US6040165 Mutant prenyl diphosphate synthase
03/21/2000US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040160 Method of producing L-lysine by fermentation
03/21/2000US6040159 Nucleotide sequence of ribonucleotides and optionally deoxyribonucleotides with optionally modified phosphates and hydrogen bonded to itself; targeted against tumor necrosis factor; for antiarthritic agents, antisense agents, viricides
03/21/2000US6040157 Amino acid sequence; for angiogenesis inhibitors, antitumor agents, antiinflammatory agents, antiarthritic agents for rheumatoid arthritis, wound healing agents; treatment of diabetic retinopathy and psoriasis
03/21/2000US6040156 Amino acid sequence of enzyme capable of transferring glucuronic acid from donor to acceptor molecule; involved in synthesis of the hnk-1 (natural killer t-cell) epitope expressed on neuronal or immune cells
03/21/2000US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects
03/21/2000US6040146 Detection of mammary tumor virus-like sequences in human breast cancer
03/21/2000US6040144 Procedure for preparing gene expression libraries enriched for secretory protein genes
03/21/2000US6040142 Method and probes for detecting markers linked to the infantile spinal muscular atrophy locus
03/21/2000US6040141 Bacterium possessing the markers fpt, ompt-- and dsba--; for expression of fusion protein on surface of bacterium
03/21/2000US6040138 Expression monitoring by hybridization to high density oligonucleotide arrays
03/21/2000US6040136 Phagemid expression vector having a transcription regulatory sequence linked to gene encoding a fusion protein of a polypeptide and a bacteriophage coat protein; for library of proteins expressed in low quantity on particle surface
03/21/2000US6039941 Live vaccine for the treatment of tumor diseases
03/21/2000CA2093423C Detergent compositions containing substantially pure eg iii cellulase
03/21/2000CA2030518C Osteoinductive compositions
03/16/2000WO2000014545A1 Multihued labels
03/16/2000WO2000014544A1 Chemiluminescent immunoassay for detection of antibodies to various viruses
03/16/2000WO2000014536A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
03/16/2000WO2000014281A2 Assays using crosslinkable immobilized nucleic acids
03/16/2000WO2000014277A1 Method for amplifying all dna fragments in a sample
03/16/2000WO2000014276A2 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids
03/16/2000WO2000014275A2 Two-colour differential display, used as a method for detecting regulated genes
03/16/2000WO2000014272A1 Measurement of persistent-latent hiv viral load
03/16/2000WO2000014271A1 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO)
03/16/2000WO2000014267A1 Biosensor
03/16/2000WO2000014265A1 Enzymatic oxidative deamination process
03/16/2000WO2000014263A2 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
03/16/2000WO2000014262A2 Methylation of plasmid vectors
03/16/2000WO2000014261A1 Production of human erythropoietin
03/16/2000WO2000014260A1 Methods for controlling viral diseases in plants
03/16/2000WO2000014259A1 Candida boidinii strains having lowered protease activity and utilization thereof as host for producing foreign protein
03/16/2000WO2000014258A1 Method for the production of heterologous polypeptides in transformed yeast cells
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014255A1 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES
03/16/2000WO2000014254A2 Component of bromelain
03/16/2000WO2000014253A1 Nucleic acids and proteins from pineapple stem
03/16/2000WO2000014252A1 Prodrug ribozyme
03/16/2000WO2000014251A2 Human transferase proteins
03/16/2000WO2000014250A1 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/16/2000WO2000014249A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000WO2000014247A2 Agents and methods for modifying the glutamine metabolism in plants, especially in sugar beet
03/16/2000WO2000014246A1 Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof
03/16/2000WO2000014245A1 Dengue viruses that are replication defective in mosquitos for use as vaccines
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014243A1 Phenolic acid esterases, coding sequences and methods
03/16/2000WO2000014242A1 Novel protein, gene encoding the same and utilization thereof
03/16/2000WO2000014241A1 Novel gene
03/16/2000WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers
03/16/2000WO2000014239A2 Thioredoxin h homologs
03/16/2000WO2000014238A1 Maize repair protein orthologue-1 and uses thereof
03/16/2000WO2000014237A2 17 kDa FOAM PROTEIN
03/16/2000WO2000014236A2 Grf analogs with increased biological potency
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014234A1 Prostate specific promoter and regulation of gene expression
03/16/2000WO2000014233A1 14275 receptor, a novel g-protein coupled receptor related to the edg receptor family
03/16/2000WO2000014232A1 Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1)
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014229A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014227A1 Novel protein and dna thereof
03/16/2000WO2000014226A1 Novel protein and process for producing the same
03/16/2000WO2000014225A1 Putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits, cacnglike2 (calcium channel gamma like 2)
03/16/2000WO2000014224A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits
03/16/2000WO2000014223A1 Voltage-gated calcium channel
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014221A1 Glycine transporter
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000WO2000014219A2 Peptide nucleic acid-oligoadenylate chimeric molecules
03/16/2000WO2000014218A1 Method for synthesizing dna
03/16/2000WO2000014217A2 G-motif oligonucleotides and uses thereof
03/16/2000WO2000014216A1 Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor
03/16/2000WO2000014215A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method
03/16/2000WO2000014214A1 Antibodies for judging possibility of the onset of bovine leukemia